#128545
Re: Farmas USA
Muchas gracias por la aclaracion y toda esa info.
Sarepta Therapeutics Reports Positive Clinical Results from Phase 2 MOMENTUM Study of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 51